GSK backs BMJ’s new policy to publish only studies with full access to data

@article{Kmietowicz2012GSKBB,
  title={GSK backs BMJ’s new policy to publish only studies with full access to data},
  author={Z. Kmietowicz},
  journal={BMJ : British Medical Journal},
  year={2012},
  volume={345}
}
  • Z. Kmietowicz
  • Published 2012
  • Medicine
  • BMJ : British Medical Journal
  • The announcement this week that the BMJ will publish clinical trials only if the researchers have agreed to provide detailed patient level data when requested has been applauded by the drug firm GlaxoSmithKline. Fiona Godlee, editor in chief of the BMJ , said in an editorial that the journal “will require this commitment for all clinical trials of drugs and devices—whether industry funded or not—from January 2013.”1 In response, Patrick Vallance, president of pharmaceuticals research and… CONTINUE READING
    1 Citations

    Topics from this paper

    References

    SHOWING 1-5 OF 5 REFERENCES
    Health minister agrees to meet academics to discuss access to clinical trial data
    • 5
    GlaxoSmithKline grants researchers access to clinical trial data
    • R. Coombes
    • Medicine
    • BMJ : British Medical Journal
    • 2012
    • 12
    Academics plea for politicians to tackle problem of missing data
    • 4
    Clinical trial data for all drugs in current use
    • F. Godlee
    • Medicine
    • BMJ : British Medical Journal
    • 2012
    • 57
    • PDF